Newsfeeds Archive - Page 2 of 31

2 minute read

Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another

May 16, 12:11 PM

Ionis Pharmaceuticals and Biogen have halted development of BIIB105 for ALS after Phase 1/2 study results showed no impact on key clinical outcomes.

BIIB

2 minute read

Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank

By Avi Kapoor

May 13, 9:15 AM

Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a favorite."

BAC

4 minute read

Analyst Ratings

The Analyst Landscape: 27 Takes On Biogen

By Benzinga Insights

April 29, 1:01 PM

In the preceding three months, 27 analysts have released ratings for Biogen (NASDAQ:BIIB), presenting a wide array of…

BIIB

3 minute read

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

By Shanthi Rexaline

April 29, 1:51 AM

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

AAL

1 minute read

These Analysts Revise Their Forecasts On Biogen After Q1 Results

By Avi Kapoor

April 25, 8:53 AM

Biogen Inc (NASDAQ:BIIB) reported better-than-expected earnings for its first quarter on Wednesday. Biogen reported first-quarter adjusted EPS of…

BIIB

2 minute read

Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday

By Avi Kapoor

April 25, 8:44 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

BIIB

2 minute read

Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why

By Vandana Singh

April 24, 2:23 PM

Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA approval.

BIIB

2 minute read

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What’s Driving Markets Wednesday?

By Piero Cingari

April 24, 1:40 PM

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the highest level since early November, ahead of crucial economic data on Thursday.

2 minute read

Biogen’s Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings

By Vandana Singh

April 24, 12:12 PM

Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging.

BIIB

4 minute read

Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally

By Shanthi Rexaline

April 24, 6:37 AM

Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m

BIIB